Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 1/2003

01.11.2003 | Original Article

Effects of insulin on luteinizing hormone and prolactin secretion and calcium signaling in female rat pituitary cells

verfasst von: J. M. Weiss, S. Polack, K. Diedrich, O. Ortmann

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 1/2003

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Polycystic ovary syndrome (PCOS) is associated with insulin resistance and hyperinsulinemia, which might contribute to the hypersecretion of luteinizing hormone (LH). Hyperprolactinemia is another finding in a subgroup of patients with PCOS, whereas its relation to hyperinsulinemia is not fully understood yet.

Methods

In the present study we tested the hypothesis that insulin might affect LH or prolactin secretion of cultured female rat pituitary cells. To address the mechanisms by which insulin could act at the intracellular level we examined the GnRH- and TRH-induced Ca2+ signals in single gonadotrophs and lactotrophs, because Ca2+ is an important component of GnRH signal transduction that is closely related to exocytosis.

Results

Cells treated for 24 h with insulin (10−9 M) showed an enhancement of basal and agonist-induced LH and prolactin secretion. Insulin did not affect GnRH- and TRH-induced Ca2+ signals compared to controls. There were no differences neither in the frequency nor in the amplitude of the Ca signal.

Conclusion

Our findings suggest that insulin might contribute to LH hypersecretion. Insulin might be partially responsible for hyperprolactinemia. Since insulin did not affect Ca signaling, other components of the GnRH signal transduction pathway might be involved in LH hypersecretion.
Literatur
1.
Zurück zum Zitat Abdel-Gadir A, Khatim MS, Mowafi RS et al (1992) Implications of ultrasonically diagnosed polycystic ovaries. II. Studies of dynamic and pulsatile hormonal patterns. Hum Reprod 7:458–461CrossRefPubMed Abdel-Gadir A, Khatim MS, Mowafi RS et al (1992) Implications of ultrasonically diagnosed polycystic ovaries. II. Studies of dynamic and pulsatile hormonal patterns. Hum Reprod 7:458–461CrossRefPubMed
2.
Zurück zum Zitat Adashi EY, Hsueh AJ, Yen SS (1981) Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells. Endocrinology 108:1441–1449CrossRefPubMed Adashi EY, Hsueh AJ, Yen SS (1981) Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells. Endocrinology 108:1441–1449CrossRefPubMed
3.
Zurück zum Zitat Balen AH (1993) Hypersecretion of luteinizing hormone and the polycystic ovary syndrome. Hum Reprod 8 [Suppl 2]:123–128CrossRefPubMed Balen AH (1993) Hypersecretion of luteinizing hormone and the polycystic ovary syndrome. Hum Reprod 8 [Suppl 2]:123–128CrossRefPubMed
4.
Zurück zum Zitat Belisle S, Menard J (1980) Adrenal androgen production in hyperprolactinemic states. Fertil Steril 33:396–400CrossRefPubMed Belisle S, Menard J (1980) Adrenal androgen production in hyperprolactinemic states. Fertil Steril 33:396–400CrossRefPubMed
5.
Zurück zum Zitat Bracero N, Zacur HA (2001) Polycystic ovary syndrome and hyperprolactinemia. Obstet Gynecol Clin North Am 28:77–84CrossRefPubMed Bracero N, Zacur HA (2001) Polycystic ovary syndrome and hyperprolactinemia. Obstet Gynecol Clin North Am 28:77–84CrossRefPubMed
6.
Zurück zum Zitat Brann DW, Mashesh VB (1991) Regulation of gonadotropin secretion by steroid hormones. Front Neuroendocr 12:165–70 Brann DW, Mashesh VB (1991) Regulation of gonadotropin secretion by steroid hormones. Front Neuroendocr 12:165–70
7.
Zurück zum Zitat Clapp DH, Wiebe RH (1983) The effect of hyperprolactinemia on the diurnal variation of adrenal androgens. Fertil Steril 39:749–752CrossRefPubMed Clapp DH, Wiebe RH (1983) The effect of hyperprolactinemia on the diurnal variation of adrenal androgens. Fertil Steril 39:749–752CrossRefPubMed
8.
Zurück zum Zitat Dunaif A, Scott D, Finegood D et al (1996) The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. J Clin Endocrinol Metab 81:3299–3306PubMed Dunaif A, Scott D, Finegood D et al (1996) The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. J Clin Endocrinol Metab 81:3299–3306PubMed
9.
Zurück zum Zitat Ehrmann DA, Barnes RB, Rosenfield RL (1995) Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev 16:322–353CrossRefPubMed Ehrmann DA, Barnes RB, Rosenfield RL (1995) Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev 16:322–353CrossRefPubMed
10.
Zurück zum Zitat Ehrmann DA, Schneider DJ, Sobel BE et al (1997) Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome. J Clin Endocrinol Metab 82:2108–2116PubMed Ehrmann DA, Schneider DJ, Sobel BE et al (1997) Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome. J Clin Endocrinol Metab 82:2108–2116PubMed
12.
Zurück zum Zitat Fulghesu AM, Lanzone A, Andreani CL et al (1995) Effectiveness of a somatostatin analogue in lowering luteinizing hormone and insulin-stimulated secretion in hyperinsulinemic women with polycystic ovary disease. Fertil Steril 64:703–708CrossRefPubMed Fulghesu AM, Lanzone A, Andreani CL et al (1995) Effectiveness of a somatostatin analogue in lowering luteinizing hormone and insulin-stimulated secretion in hyperinsulinemic women with polycystic ovary disease. Fertil Steril 64:703–708CrossRefPubMed
13.
Zurück zum Zitat Higuchi K, Nawata H, Maki T et al (1984) Prolactin has a direct effect on adrenal androgen secretion. J Clin Endocrinol Metab 59:714–718CrossRefPubMed Higuchi K, Nawata H, Maki T et al (1984) Prolactin has a direct effect on adrenal androgen secretion. J Clin Endocrinol Metab 59:714–718CrossRefPubMed
14.
Zurück zum Zitat Iuorno MJ, Nestler JE (2001) Insulin-lowering drugs in polycystic ovary syndrome. Obstet Gynecol Clin North Am 28:153–164CrossRefPubMed Iuorno MJ, Nestler JE (2001) Insulin-lowering drugs in polycystic ovary syndrome. Obstet Gynecol Clin North Am 28:153–164CrossRefPubMed
15.
Zurück zum Zitat Kawaguchi M, Funabashi T, Kimura F (1998) Insulin-induced hypoglycemia does not impair the surge of luteinizing hormone secretion in the proestrus rat. Neurosci Lett 256:131–134CrossRefPubMed Kawaguchi M, Funabashi T, Kimura F (1998) Insulin-induced hypoglycemia does not impair the surge of luteinizing hormone secretion in the proestrus rat. Neurosci Lett 256:131–134CrossRefPubMed
16.
Zurück zum Zitat Nestler JE (1997) Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implications. Semin Reprod Endocrinol 15:111–122CrossRefPubMed Nestler JE (1997) Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implications. Semin Reprod Endocrinol 15:111–122CrossRefPubMed
17.
Zurück zum Zitat Nestler JE, Jakubowicz DJ (1996) Decreases in ovarian cytochrome P450c17α activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med 335:617–623CrossRefPubMed Nestler JE, Jakubowicz DJ (1996) Decreases in ovarian cytochrome P450c17α activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med 335:617–623CrossRefPubMed
18.
Zurück zum Zitat Ortmann O, Merelli F, Stojilkovic SS, Schulz KD, Emons G, Catt KJ (1994) Modulation of calcium signaling and LH secretion by progesterone in pituitary gonadotrophs and clonal pituitary cells. J Steroid Biochem Mol Biol 48:47–54CrossRefPubMed Ortmann O, Merelli F, Stojilkovic SS, Schulz KD, Emons G, Catt KJ (1994) Modulation of calcium signaling and LH secretion by progesterone in pituitary gonadotrophs and clonal pituitary cells. J Steroid Biochem Mol Biol 48:47–54CrossRefPubMed
19.
Zurück zum Zitat Ortmann O, Bakhit M, Bloh P et al (1995) Ovarian steroids modulate gonadotropin-releasing hormone-induced biphasic luteinizing hormone secretory responses and inositol phosphate accumulation in rat anterior pituitary cells and alpha T3–1 gonadotrophs. J Steroid Biochem Mol Biol 54:101–109CrossRefPubMed Ortmann O, Bakhit M, Bloh P et al (1995) Ovarian steroids modulate gonadotropin-releasing hormone-induced biphasic luteinizing hormone secretory responses and inositol phosphate accumulation in rat anterior pituitary cells and alpha T3–1 gonadotrophs. J Steroid Biochem Mol Biol 54:101–109CrossRefPubMed
20.
Zurück zum Zitat Ortmann O, Tomic M, Weiss JM et al (1998) Dual action of androgen on calcium signaling and luteinizing hormone secretion in pituitary gonadotrophs. Cell Calcium 24:223–231CrossRefPubMed Ortmann O, Tomic M, Weiss JM et al (1998) Dual action of androgen on calcium signaling and luteinizing hormone secretion in pituitary gonadotrophs. Cell Calcium 24:223–231CrossRefPubMed
21.
Zurück zum Zitat Pugeat M, Ducluzeau PH (1999) Insulin resistance, polycystic ovary syndrome and metformin. Drugs 58:41–46CrossRefPubMed Pugeat M, Ducluzeau PH (1999) Insulin resistance, polycystic ovary syndrome and metformin. Drugs 58:41–46CrossRefPubMed
22.
Zurück zum Zitat Soldani R, Cagnacci A, Yen SS (1994) Insulin, insulin-like growth factor I (IGF-I) and IGF-II enhance basal and gonadotrophin-releasing hormone-stimulated luteinizing hormone release from rat anterior pituitary cells in vitro. Eur J Endocrinol 131:641–645CrossRefPubMed Soldani R, Cagnacci A, Yen SS (1994) Insulin, insulin-like growth factor I (IGF-I) and IGF-II enhance basal and gonadotrophin-releasing hormone-stimulated luteinizing hormone release from rat anterior pituitary cells in vitro. Eur J Endocrinol 131:641–645CrossRefPubMed
23.
Zurück zum Zitat Soldani R, Cagnacci A, Paletti AM et al (1995) Modulation of anterior pituitary luteinizing hormone response to gonadotropin-releasing hormone by insulin-like growth factor I in vitro. Fertil Steril 64:634–637CrossRefPubMed Soldani R, Cagnacci A, Paletti AM et al (1995) Modulation of anterior pituitary luteinizing hormone response to gonadotropin-releasing hormone by insulin-like growth factor I in vitro. Fertil Steril 64:634–637CrossRefPubMed
24.
Zurück zum Zitat Stojilkovic SS, Catt KJ (1995) Expression and signal transduction pathways of gonadotropin-releasing hormone receptors. Recent Prog Horm Res 50:161–205PubMed Stojilkovic SS, Catt KJ (1995) Expression and signal transduction pathways of gonadotropin-releasing hormone receptors. Recent Prog Horm Res 50:161–205PubMed
25.
Zurück zum Zitat Stojilkovic SS, Stutzin A, Izumi SI et al (1990) Generation and amplification of the cytosolic calcium signal during secretory responses to gonadotropin-releasing hormone. New Biol 2:272–283PubMed Stojilkovic SS, Stutzin A, Izumi SI et al (1990) Generation and amplification of the cytosolic calcium signal during secretory responses to gonadotropin-releasing hormone. New Biol 2:272–283PubMed
26.
Zurück zum Zitat Thomas AP, Bird GS, Hajnoczky G, Robb-Gaspers LD, Putney JW Jr (1996) Spatial and temporal aspects of cellular calcium signaling. FASEB J 13:1505–1517CrossRef Thomas AP, Bird GS, Hajnoczky G, Robb-Gaspers LD, Putney JW Jr (1996) Spatial and temporal aspects of cellular calcium signaling. FASEB J 13:1505–1517CrossRef
27.
Zurück zum Zitat Tse A, Tse FW, Hille B, Horstmann H, Almers W (1997) Local Ca2+ release from internal stores controls exocytosis in pituitary gonadotrophs. Neuron 18:121–132CrossRefPubMed Tse A, Tse FW, Hille B, Horstmann H, Almers W (1997) Local Ca2+ release from internal stores controls exocytosis in pituitary gonadotrophs. Neuron 18:121–132CrossRefPubMed
28.
Zurück zum Zitat Velazquez E, Acosta A, Mendoza SG (1997) Menstrual cyclicity after metformin therapy in polycystic ovary syndrome. Obstet Gynecol 90:392–395CrossRefPubMed Velazquez E, Acosta A, Mendoza SG (1997) Menstrual cyclicity after metformin therapy in polycystic ovary syndrome. Obstet Gynecol 90:392–395CrossRefPubMed
29.
Zurück zum Zitat Willis D, Franks S (1996) Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin receptor and not the type-I insulin-like growth factor receptor. J Clin Endocrinol Metab 80: 3788–3790CrossRef Willis D, Franks S (1996) Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin receptor and not the type-I insulin-like growth factor receptor. J Clin Endocrinol Metab 80: 3788–3790CrossRef
30.
Zurück zum Zitat Xia YX, Weiss JM, Polack S, Diedrich K, Ortmann O (2000) Interactions of insulin-like growth factor I, insulin, and estradiol on GnRH-stimulated luteinizing hormone release from female rat gonadotrophs. Eur J Endocrinol 144:73–79 Xia YX, Weiss JM, Polack S, Diedrich K, Ortmann O (2000) Interactions of insulin-like growth factor I, insulin, and estradiol on GnRH-stimulated luteinizing hormone release from female rat gonadotrophs. Eur J Endocrinol 144:73–79
Metadaten
Titel
Effects of insulin on luteinizing hormone and prolactin secretion and calcium signaling in female rat pituitary cells
verfasst von
J. M. Weiss
S. Polack
K. Diedrich
O. Ortmann
Publikationsdatum
01.11.2003
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 1/2003
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-003-0506-9

Weitere Artikel der Ausgabe 1/2003

Archives of Gynecology and Obstetrics 1/2003 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.